Emmyon discovers and develops small molecules that improve muscle mass, strength, exercise capacity and metabolism. Emmyon is working to develop, through partnerships, pharmaceutical and nutraceutical products that enable a positive impact on important and growing markets; including sports nutrition, healthy aging, muscle atrophy, obesity, diabetes, and animal health.

Venture Information
Stage: 
Pre-Clinical
Technology or Science Area: 
Small Molecule Therapies
Market: 
Metabolic Pharmaceuticals and Nutraceuticals
Company Information
Founders: 
Christopher Adams, MD, PhD
Michael Welsh, MD
Company Location: 
Coralville, IA